Verification of Survival Predictors in Elderly Patients with
Myelodysplastic Syndrome from Outpatient Clinical Practice

J 2018

Verification of Survival Predictors in Elderly Patients with Myelodysplastic Syndrome from Outpatient Clinical Practice

KADLČKOVÁ, Eva, Peter ROHOŇ, Tomáš FÜRST, Libor ČERVINEK, Andrea JONÁŠOVÁ et. al.

Basic information

Original name

Verification of Survival Predictors in Elderly Patients with Myelodysplastic Syndrome from Outpatient Clinical Practice

Authors

KADLČKOVÁ, Eva (203 Czech Republic, guarantor), Peter ROHOŇ (203 Czech Republic), Tomáš FÜRST (203 Czech Republic), Libor ČERVINEK (203 Czech Republic, belonging to the institution), Andrea JONÁŠOVÁ (203 Czech Republic), Tomáš ŠÁLEK (203 Czech Republic), Jiří TESAŘ (203 Czech Republic) and Yvetta STAVAŘOVÁ (203 Czech Republic)

Edition

INTERNATIONAL JOURNAL OF GERONTOLOGY, TAIPEI, ELSEVIER TAIWAN, 2018, 1873-9598

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30227 Geriatrics and gerontology

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 0.933

RIV identification code

RIV/00216224:14110/18:00104088

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1016/j.ijge.2017.06.001

UT WoS

000428286500007

Keywords in English

chelation therapy; myelodysplastic syndrome; prognostic scoring system; transfusion

Abstract

V originále

Background: Myelodysplastic syndrome (MDS) is a clonal disorder affecting older persons. We aimed to analyze the effectiveness of the scoring systems and of the number of received red blood cell (RBC) units in predicting survival. Methods: The study included an unselected group of 73 patients with MDS who were diagnosed and treated in a single hospital over a period of 12 years. International Prognostic Scoring System (IPSS), revised IPSS (IPSS-R), WHO-Prognostic Scoring System (WPSS), Charlson Age-Comorbidity Index (CACI), and impact of performance status (PS) on overall survival (OS) and event free survival (EFS) were tested. The follow-up of received RBC units was conducted. Results: The median age at diagnosis was 69.5 years, the median CACI was 3.0. The median survival times of the group were 7.04 and 2.78 years for OS and EFS, respectively. The concordance values of the IPSS, IPSS-R and WPSS are 0.812, 0.892 and 0.889 for OS; 0.785, 0.847 and 0.827 for EFS. The comorbidity index and PS were the only auxiliary criteria when determining the risk and selecting the therapeutic approach in MDS patients. In transfusion-dependent unchelated patients, both OS and EFS were negatively influenced by both higher ferritin levels and the numbers of RBC units; however, the risk does not continue to increase after more than 20 RBC units are administered. Conclusions: IPSS-R is best suited as a predictor of survival. CACI and PS present auxiliary criteria for determining the risk. Number of received RBC units was detected as a significant predictor of survival. Copyright (c) 2017, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier Taiwan LLC.

Citovat

KADLČKOVÁ, Eva, Peter ROHOŇ, Tomáš FÜRST, Libor ČERVINEK, Andrea JONÁŠOVÁ, Tomáš ŠÁLEK, Jiří TESAŘ and Yvetta STAVAŘOVÁ. Verification of Survival Predictors in Elderly Patients with Myelodysplastic Syndrome from Outpatient Clinical Practice. INTERNATIONAL JOURNAL OF GERONTOLOGY. TAIPEI: ELSEVIER TAIWAN, 2018, vol. 12, No 1, p. 27-31. ISSN 1873-9598. Available from: https://dx.doi.org/10.1016/j.ijge.2017.06.001.

@article{1451477,
   author = {Kadlčková, Eva and Rohoň, Peter and Fürst, Tomáš and Červinek, Libor and Jonášová, Andrea and Šálek, Tomáš and Tesař, Jiří and Stavařová, Yvetta},
   article_location = {TAIPEI},
   article_number = {1},
   doi = {http://dx.doi.org/10.1016/j.ijge.2017.06.001},
   keywords = {chelation therapy; myelodysplastic syndrome; prognostic scoring system; transfusion},
   language = {eng},
   issn = {1873-9598},
   journal = {INTERNATIONAL JOURNAL OF GERONTOLOGY},
   title = {Verification of Survival Predictors in Elderly Patients with Myelodysplastic Syndrome from Outpatient Clinical Practice},
   volume = {12},
   year = {2018}
}

TY  - JOUR
ID  - 1451477
AU  - Kadlčková, Eva - Rohoň, Peter - Fürst, Tomáš - Červinek, Libor - Jonášová, Andrea - Šálek, Tomáš - Tesař, Jiří - Stavařová, Yvetta
PY  - 2018
TI  - Verification of Survival Predictors in Elderly Patients with Myelodysplastic Syndrome from Outpatient Clinical Practice
JF  - INTERNATIONAL JOURNAL OF GERONTOLOGY
VL  - 12
IS  - 1
SP  - 27-31
EP  - 27-31
PB  - ELSEVIER TAIWAN
SN  - 18739598
KW  - chelation therapy
KW  - myelodysplastic syndrome
KW  - prognostic scoring system
KW  - transfusion
N2  - Background: Myelodysplastic syndrome (MDS) is a clonal disorder affecting older persons. We aimed to analyze the effectiveness of the scoring systems and of the number of received red blood cell (RBC) units in predicting survival. Methods: The study included an unselected group of 73 patients with MDS who were diagnosed and treated in a single hospital over a period of 12 years. International Prognostic Scoring System (IPSS), revised IPSS (IPSS-R), WHO-Prognostic Scoring System (WPSS), Charlson Age-Comorbidity Index (CACI), and impact of performance status (PS) on overall survival (OS) and event free survival (EFS) were tested. The follow-up of received RBC units was conducted. Results: The median age at diagnosis was 69.5 years, the median CACI was 3.0. The median survival times of the group were 7.04 and 2.78 years for OS and EFS, respectively. The concordance values of the IPSS, IPSS-R and WPSS are 0.812, 0.892 and 0.889 for OS; 0.785, 0.847 and 0.827 for EFS. The comorbidity index and PS were the only auxiliary criteria when determining the risk and selecting the therapeutic approach in MDS patients. In transfusion-dependent unchelated patients, both OS and EFS were negatively influenced by both higher ferritin levels and the numbers of RBC units; however, the risk does not continue to increase after more than 20 RBC units are administered. Conclusions: IPSS-R is best suited as a predictor of survival. CACI and PS present auxiliary criteria for determining the risk. Number of received RBC units was detected as a significant predictor of survival. Copyright (c) 2017, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier Taiwan LLC.
ER  -

KADLČKOVÁ, Eva, Peter ROHOŇ, Tomáš FÜRST, Libor ČERVINEK, Andrea JONÁŠOVÁ, Tomáš ŠÁLEK, Jiří TESAŘ and Yvetta STAVAŘOVÁ. Verification of Survival Predictors in Elderly Patients with Myelodysplastic Syndrome from Outpatient Clinical Practice. \textit{INTERNATIONAL JOURNAL OF GERONTOLOGY}. TAIPEI: ELSEVIER TAIWAN, 2018, vol.~12, No~1, p.~27-31. ISSN~1873-9598. Available from: https://dx.doi.org/10.1016/j.ijge.2017.06.001.

Detailed Information on Publication Record